Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US8080551 | GILEAD SCIENCES INC | HIV inhibiting pyrimidines derivatives |
Apr, 2023
(8 days from now) | |
US7125879 | GILEAD SCIENCES INC | HIV inhibiting pyrimidines derivatives |
Apr, 2025
(2 years from now) | |
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8101629 | GILEAD SCIENCES INC | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
Aug, 2022
(7 months ago) | |
US8716264 | GILEAD SCIENCES INC | Compositions and methods for combination antiviral therapy |
Jan, 2024
(9 months from now) | |
US9744181 | GILEAD SCIENCES INC | Compositions and methods for combination antiviral therapy |
Jan, 2024
(9 months from now) | |
US8592397 | GILEAD SCIENCES INC | Compositions and methods for combination antiviral therapy |
Jan, 2024
(9 months from now) | |
US9457036 | GILEAD SCIENCES INC | Compositions and methods for combination antiviral therapy |
Jan, 2024
(9 months from now) | |
US8841310 | GILEAD SCIENCES INC | Combinations of a pyrimidine containing NNRTI with RT inhibitors |
Dec, 2025
(2 years from now) | |
US10857102 | GILEAD SCIENCES INC | Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate |
Jan, 2033
(9 years from now) |
Market Authorisation Date: 10 August, 2011
Treatment: Treatment of hiv infection
Dosage: TABLET;ORAL
49
United States
25
European Union
20
Norway
19
Japan
14
Australia
13
Hungary
12
China
11
Korea, Republic of
9
Croatia
8
Hong Kong
8
Argentina
8
Brazil
8
Spain
8
EA
7
Denmark
7
Slovenia
7
Poland
7
Taiwan, Province of China
7
Canada
6
Israel
6
Mexico
6
Lithuania
6
AP
6
Portugal
6
New Zealand
5
South Africa
5
Cyprus
5
Luxembourg
5
Ukraine
4
Austria
4
Singapore
3
Belgium
3
Costa Rica
3
Malaysia
3
Peru
2
Germany
2
RS
2
Ecuador
2
Nicaragua
2
ME
1
OA
1
Egypt
1
Jordan
1
Morocco
1
Colombia
1
Netherlands
1
San Marino
1
Iceland
1
Chile
1
Panama
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic